Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study

The Lancet

Volumn 391, Issue 10133, 2018, Pages 1897-1907

  Pylypchuk, Romana ^a   Wells, Sue ^a   Kerr, Andrew ^a,b   Poppe, Katrina ^a   Riddell, Tania ^a   Harwood, Matire ^a   Exeter, Dan ^a   Mehta, Suneela ^a   Grey, Corina ^a   Wu, Billy P ^a   Metcalf, Patricia ^a   Warren, Jim ^c   Harrison, Jeff ^a   Marshall, Roger ^a   Jackson, Rod ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CHINESE; CLINICAL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA BASE; ETHNICITY; EUROPEAN; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GENERAL PRACTITIONER; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INDIAN; INTERNATIONAL CLASSIFICATION OF DISEASES; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MAORI (PEOPLE); MORTALITY; NEW ZEALAND; OUTCOME ASSESSMENT; POOLED COHORT EQUATION; POPULATION RESEARCH; PREDICT EQUATION; PREDICTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SOCIOECONOMICS; SOFTWARE; UNITED STATES; VALIDATION STUDY; ALGORITHM; ANCESTRY GROUP; ETHNIC GROUP; MIDDLE AGED; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ALGORITHMS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 85046645662     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(18)30664-0     Document Type: Article

References (43)

1. Kannel, WB, Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 37 (1976), 269–282.
2. Mihaylova, B, Emberson, J, Blackwell, L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380 (2012), 581–590.
3. Sundström, J, Jackson, R, Neal, B, for the BPLTTC. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 384 (2014), 591–598.
4. New Zealand Guideline Group. Assessment and management of cardiovascular risk. http://www.health.govt.nz/publication/assessment-and-management-cardiovascular-risk, 2003. (Accessed 24 January 2018)
5. Task Force. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur J Cardiovasc Prev Rehab 14:suppl 2 (2007), E1–E40.
6. Rabar, S, Harker, M, O'Flynn, N, Wierzbicki, AS, Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ, 349, 2014, g4356.
7. Goff, DC Jr, Lloyd-Jones, DM, Bennett, G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:25 suppl 2 (2014), S49–S73.
8. Stone, N, Robinson, J, Lichtenstein, A, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:25 suppl 2 (2014), S1–S45.
9. Whelton, PK, Carey, RM, Aronow, WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 2017 published online Nov 13. DOI:10.1161/HYP.0000000000000065.
10. Damen, JA, Hooft, L, Schuit, E, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ, 353, 2016, i2416.
11. Jackson, R, Barham, P, Maling, T, et al. The management of raised blood pressure in New Zealand. BMJ 307 (1993), 107–110.
12. Anderson, KV, Odell, PM, Wilson, PWF, Kannel, WB, Cardiovascular disease risk profiles. Am Heart J 121 (1991), 293–298.
13. Wells, S, Riddell, T, Kerr, A, et al. Cohort profile: the PREDICT Cardiovascular Disease Cohort in New Zealand primary care (PREDICT-CVD 19). Int J Epidemiol, 46, 2015, 22.
14. New Zealand Ministry of Health. Primary care data and stats. http://www.health.govt.nz/nz-health-statistics/health-statistics-and-data-sets/primary-care-data-and-stats. (Accessed 24 January 2018)
15. New Zealand Ministry of Health. More heart and diabetes checks. http://www.health.govt.nz/publication/more-heart-and-diabetes-checks-evaluation. (Accessed 24 January 2018)
16. New Zealand Ministry of Health. National Health Index. http://www.health.govt.nz/our-work/health-identity/national-health-index. (Accessed 24 January 2018)
17. University of Otago. Socioeconomic deprivation indexes: NZDep and NZiDep. http://www.otago.ac.nz/wellington/departments/publichealth/research/hirp/otago020194.html. (Accessed 24 January 2018)
18. Cox, D, Regression models and life-tables. J R Stat Soc Series B 34 (1972), 187–220.
19. Schoenfeld, D, Partial residuals for the proportional hazards regression model. Biometrika 69 (1982), 239–241.
20. Belsley, D, Kuh, E, Welsch, R, Regression diagnostics: identifying influential data and sources of collinearity. 1980, Wiley, New York, NY.
21. Therneau, T, Grambsch, P, Fleming, T, Martingale-based residuals for survival models. Biometrika 77 (1990), 147–160.
22. Royston, P, Sauerbrei, W, Multivariable model-building. A pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. 2008, John Wiley & Sons, New York, NY.
23. StataCorp. Stata Statistical Software. Release 13. 2013, StataCorp LP, College Station, TX.
24. Kaplan, E, Meier, P, Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958), 457–481.
25. Royston, P, Explained variation for survival models. Stata J 6 (2006), 83–96.
26. Harrell, F, Califf, R, Prior, D, Lee, K, Rosati, R, Evaluating the yield of medical tests. JAMA 247 (1982), 2543–2546.
27. Royston, P, Sauerbrei, W, A new measure of prognostic separation in survival data. Stat Med 23 (2004), 723–748.
28. Steyerberg, EW, Clinical prediction models. A practical approach to development, validation and updating. 2008, Springer, London.
29. Moons, KG, Altman, DG, Reitsma, JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162 (2015), W1–W73.
30. Muntner, P, Colantonio, LD, Cushman, M, et al. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA 311 (2014), 1406–1415.
31. Crowson, CS, Atkinson, EJ, Therneau, TM, Assessing calibration of prognostic risk scores. Stat Methods Med Res 25 (2016), 1692–1706.
32. Royston, P, Altman, DG, External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol, 13, 2013, 33.
33. Institute for Health Metrics and Evaluation, University of Washington. Causes of death visualization. https://vizhub.healthdata.org/cod/. (Accessed 24 January 2018)
34. Liew, SM, Doust, J, Glasziou, P, Cardiovascular risk scores do not account for the effect of treatment: a review. Heart 97 (2011), 689–697.
35. Grey, C, Jackson, R, Schmidt, M, et al. One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study. Eur Heart J 38 (2017), 172–180.
36. Cook, NR, Ridker, PM, Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update. Ann Intern Med 165 (2016), 786–794.
37. Hippisley-Cox, J, Coupland, C, Brindle, P, Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ, 357, 2017, j2099.
38. Merry, AH, Boer, JM, Schouten, LJ, et al. Validity of coronary heart diseases and heart failure based on hospital discharge and mortality data in the Netherlands using the cardiovascular registry Maastricht cohort study. Eur J Epidemiol 24 (2009), 237–247.
39. Phillips, RL, Liaw, W, Crampton, P, et al. How other countries use deprivation indices—and why the United States desperately needs one. Health Affairs (Project Hope) 35 (2016), 1991–1998.
40. Woodward, M, Brindle, P, Tunstall-Pedoe, H, Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 93 (2007), 172–176.
41. ASSIGN score. Estimating risk for ASSIGN visitors. http://assign-score.com/estimate-the-risk/visitors/. (Accessed 24 January 2018)
42. Cook, NR, Comments on ‘Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond’ by MJ Pencina, et al. Stat Med 27 (2008), 191–195.
43. Kooter, AJ, Kostense, PJ, Groenewold, J, Thijs, A, Sattar, N, Smulders, YM, Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence. Circulation 124 (2011), 741–745.